These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. THE SIDE-EFFECTS OF NEUROLEPTICS AS A SOURCE OF DIAGNOSTIC ERRORS. HOFF H Encephale; 1964; 53():SUPPL:165-9. PubMed ID: 14161528 [No Abstract] [Full Text] [Related]
25. [THE INFLUENCE OF ACTION OF ANTINEUROLEPTIC DRUGS ON THE NEUROLEPTIC THRESHOLD]. HAASE HJ; ZAHN M; ZSCHUCKE CF Int J Neuropsychiatry; 1965; 1():239-52. PubMed ID: 14309089 [No Abstract] [Full Text] [Related]
26. [Extrapyramidal motor side-effects of neuroleptic therapy & their treatment]. HARTMANN K; HIPPIUS H Arztl Wochensch; 1959 Apr; 14(16):307-12. PubMed ID: 13649487 [No Abstract] [Full Text] [Related]
27. RATIONAL USE OF PSYCHOPHARMACEUTIC AGENTS. SHAPIRO AK N Y State J Med; 1964 May; 64():1084-95. PubMed ID: 14147161 [No Abstract] [Full Text] [Related]
28. A CONTROLLED EVALUATION OF BUTAPERAZINE IN CHRONIC SCHIZOPHRENIC PATIENTS. BISHOP MP; GALLANT DM; NESSELHOF W; SPREHE DJ Dis Nerv Syst; 1964 Nov; 25():674-83. PubMed ID: 14236800 [No Abstract] [Full Text] [Related]
29. [Effects of tranquilizing drugs (reserpine, chlorpromazine) on extrapyramidal motility disorders]. BRANDER E Monatsschr Psychiatr Neurol; 1956; 132(2-3):81-95. PubMed ID: 13369436 [No Abstract] [Full Text] [Related]
30. [EXTRAPYRAMIDAL SYMPTOMS DUE TO THE USE OF PSYCHOPHARMACA]. BOHACEK N; HAJNSEK F; SARTORIUS N Fortschr Neurol Psychiatr Grenzgeb; 1963 Oct; 31():565-70. PubMed ID: 14095902 [No Abstract] [Full Text] [Related]
31. The implications of extrapyramidal symptoms in the treatment of schizophrenia. DENHAM J Rev Can Biol; 1961 Jun; 20():545-8. PubMed ID: 13885426 [No Abstract] [Full Text] [Related]
33. A parallel between the profile of clinical activity and the character of extrapyramidal activity of neuroleptics. CORNMAN HD Rev Can Biol; 1961 Jun; 20():575-7. PubMed ID: 13881414 [No Abstract] [Full Text] [Related]
34. [Effect of a new phenothiazine derivative--fluophenazine--on extrapyramidal manifestations of a hyperkinetic type]. REBUCCI GG G Psichiatr Neuropatol; 1962; 90():269-82. PubMed ID: 14490858 [No Abstract] [Full Text] [Related]
35. [Triflupromazine in psychiatric practice. Casuistic contribution]. BERTOLOTTI P; MASTROBUONO M; SOLIME F Riv Sper Freniatr Med Leg Alien Ment; 1962 Mar; 86():153-66. PubMed ID: 13868475 [No Abstract] [Full Text] [Related]
36. [Application of triflupromazine in neuropsychiatry]. BORLENGHI AP; MODARELLI HJ Sem Med; 1960 Apr; 116():611-3. PubMed ID: 13802865 [No Abstract] [Full Text] [Related]
37. Some comments on the psychodynamic aspects of the extrapyramidal reactions. SARWER-FONER GJ Rev Can Biol; 1961 Jun; 20():623-9. PubMed ID: 14497302 [No Abstract] [Full Text] [Related]
38. Biperiden in the treatment of phenothiazine-induced extrapyramidal reactions. MEDINA C; KRAMER MD; KURLAND AA JAMA; 1962 Dec; 182():1127-9. PubMed ID: 13934374 [No Abstract] [Full Text] [Related]
39. Laboratory determinations during treatment with triflupromazine. TOLER CS J La State Med Soc; 1960 Aug; 112():298-300. PubMed ID: 13838690 [No Abstract] [Full Text] [Related]
40. [COMPLICATIONS DURING CLINICAL THERAPY WITH PSYCHOPHARMACA]. HAEFNER H; KUTSCHER I Arztl Forsch; 1964 Jan; 18():18-36. PubMed ID: 14140626 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]